05
2018/11
Daxing District Development and Reform Commission and Daxing Biomedicine Industry Base delivered “Comprehensive Service Package”...
12
2018/09
On 12 September 2018, Stemedica completed its Phase III clinical trial of using mesenchymal stem cells to treat acute myocardial infarction ...
29
2018/09
Jiuzhitang Maker signed cooperation agreements with Novastem from Mexico and ALTACO from Kazakhstan
In September 2018, Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd. signed cooperation agreements with Mexican company Novastem ...
14
2018/09
In August 2018, Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd. signed Agreement on Co-construction of Stem Cell Clinical Research Base ...
17
2018/07
Jiuzhitang Maker’s manufacturing facility in Daxing District passed acceptance check
On 17 July 2018, Jiuzhitang Maker’s R&D and manufacturing facility in Daxing District, Beijing successfully passed acceptance check ...
11
2018/07
On 11 July 2018, Jiuzhitang stem cell project delegation visited Stemedica, hoping to accelerate cooperation between the two sides; ...
Copyright: Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
